Quality assurance for genotyping and resistance testing of Clostridium (Clostridioides) difficile isolates - experiences from the first inter-laboratory ring trial in four German speaking countries.

[1]  A. Mellmann,et al.  Defining and Evaluating a Core Genome Multilocus Sequence Typing Scheme for Genome-Wide Typing of Clostridium difficile , 2018, Journal of Clinical Microbiology.

[2]  R. Mahfouz,et al.  Molecular characterization, toxin detection and resistance testing of human clinical Clostridium difficile isolates from Lebanon. , 2018, International journal of medical microbiology : IJMM.

[3]  J Moran-Gilad,et al.  Practical issues in implementing whole-genome-sequencing in routine diagnostic microbiology. , 2017, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[4]  M. Wilcox,et al.  The ClosER study: results from a three-year pan-European longitudinal surveillance of antibiotic resistance among prevalent Clostridium difficile ribotypes, 2011-2014. , 2017, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[5]  C. Stratton,et al.  Update on Antimicrobial Resistance in Clostridium difficile: Resistance Mechanisms and Antimicrobial Susceptibility Testing , 2017, Journal of Clinical Microbiology.

[6]  D. Citron,et al.  Comparison of Clostridium difficile minimum inhibitory concentrations obtained using agar dilution vs broth microdilution methods. , 2017, Anaerobe.

[7]  G. Geginat,et al.  Management of a cluster of Clostridium difficile infections among patients with osteoarticular infections , 2017, Antimicrobial Resistance & Infection Control.

[8]  R. Saito,et al.  Comparison of agar dilution and broth microdilution methods for Clostridium difficile antimicrobial susceptibility testing. , 2016, Journal of global antimicrobial resistance.

[9]  E. Kuijper,et al.  Molecular characterisation of Czech Clostridium difficile isolates collected in 2013-2015. , 2016, International journal of medical microbiology : IJMM.

[10]  P. Tsai,et al.  Zoonotic potential of the Clostridium difficile RT078 family in Taiwan. , 2016, Anaerobe.

[11]  A. Mellmann,et al.  Real-Time Genome Sequencing of Resistant Bacteria Provides Precision Infection Control in an Institutional Setting , 2016, Journal of Clinical Microbiology.

[12]  E. Kuijper,et al.  Clostridium difficile PCR ribotypes 001 and 176 - the common denominator of C. difficile infection epidemiology in the Czech Republic, 2014. , 2016, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

[13]  C. Suetens,et al.  Survey of diagnostic and typing capacity for Clostridium difficile infection in Europe, 2011 and 2014. , 2016, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

[14]  C. Suetens,et al.  Standardised surveillance of Clostridium difficile infection in European acute care hospitals: a pilot study, 2013. , 2016, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

[15]  M. Wilcox,et al.  Enhanced surveillance of Clostridium difficile infection occurring outside hospital, England, 2011 to 2013. , 2016, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

[16]  M. Wilcox,et al.  Diversity of Clostridium difficile PCR ribotypes in Europe: results from the European, multicentre, prospective, biannual, point-prevalence study of Clostridium difficile infection in hospitalised patients with diarrhoea (EUCLID), 2012 and 2013. , 2016, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

[17]  C. Suetens,et al.  Survey of Clostridium difficile infection surveillance systems in Europe, 2011. , 2016, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

[18]  H. Ashwin,et al.  Standardised surveillance of Clostridium difficile infection in European acute care hospitals : a pilot study , 2016 .

[19]  D. Paterson,et al.  Asymptomatic Clostridium difficile colonization: epidemiology and clinical implications , 2015, BMC Infectious Diseases.

[20]  A. Simon,et al.  Epidemiology of Clostridium difficile in Germany based on a single center long-term surveillance and German-wide genotyping of recent isolates provided to the advisory laboratory for diagnostic reasons. , 2015, International journal of medical microbiology : IJMM.

[21]  Y. Carmeli,et al.  A national survey of the molecular epidemiology of Clostridium difficile in Israel: the dissemination of the ribotype 027 strain with reduced susceptibility to vancomycin and metronidazole. , 2015, Diagnostic microbiology and infectious disease.

[22]  C. Lück,et al.  DNA-Microarray-based Genotyping of Clostridium difficile , 2015, BMC Microbiology.

[23]  S. Huhulescu,et al.  Clostridium difficile ribotypes in Austria: a multicenter, hospital-based survey , 2015, Wiener klinische Wochenschrift.

[24]  M. Mulvey,et al.  Development and Validation of an Internationally-Standardized, High-Resolution Capillary Gel-Based Electrophoresis PCR-Ribotyping Protocol for Clostridium difficile , 2015, PloS one.

[25]  K. Garey,et al.  Evaluation of Portability and Cost of a Fluorescent PCR Ribotyping Protocol for Clostridium difficile Epidemiology , 2015, Journal of Clinical Microbiology.

[26]  D. Gerding,et al.  Clostridium difficile binary toxin CDT , 2013, Gut microbes.

[27]  P. Mastrantonio,et al.  Analysis of metronidazole susceptibility in different Clostridium difficile PCR ribotypes. , 2013, The Journal of antimicrobial chemotherapy.

[28]  G. Kahlmeter,et al.  Antimicrobial susceptibility testing of Clostridium difficile using EUCAST epidemiological cut-off values and disk diffusion correlates. , 2012, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[29]  Margaret A. Olsen,et al.  Burden of Clostridium difficile on the Healthcare System , 2012, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[30]  E. Kuijper,et al.  Macro and Micro Diversity of Clostridium difficile Isolates from Diverse Sources and Geographical Locations , 2012, PloS one.

[31]  R. Rennie,et al.  First Comprehensive Evaluation of the M.I.C. Evaluator Device Compared to Etest and CLSI Reference Dilution Methods for Antimicrobial Susceptibility Testing of Clinical Strains of Anaerobes and Other Fastidious Bacterial Species , 2012, Journal of Clinical Microbiology.

[32]  S. Persson,et al.  Multiplex PCR Method for Detection of Clostridium difficile tcdA, tcdB, cdtA, and cdtB and Internal In-Frame Deletion of tcdC , 2011, Journal of Clinical Microbiology.

[33]  E. Kuijper,et al.  Clostridium difficile PCR ribotype 176 in the Czech Republic and Poland , 2011, The Lancet.

[34]  E. Kuijper,et al.  Recognition of Clostridium difficile PCR-ribotypes 001, 027 and 126/078 using an extended MALDI-TOF MS system , 2011, European Journal of Clinical Microbiology and Infectious Diseases.

[35]  E. Kuijper,et al.  Clostridium difficile infection in Europe: a hospital-based survey , 2011, The Lancet.

[36]  T. Peto,et al.  Multilocus Sequence Typing of Clostridium difficile , 2009, Journal of Clinical Microbiology.

[37]  T. Brüning,et al.  Rapid detection of the Clostridium difficile ribotype 027 tcdC gene frame shift mutation at position 117 by real-time PCR and melt curve analysis , 2009, European Journal of Clinical Microbiology & Infectious Diseases.

[38]  E. Kuijper,et al.  Emergence of reduced susceptibility to metronidazole in Clostridium difficile. , 2008, The Journal of antimicrobial chemotherapy.

[39]  E. Kuijper,et al.  Characterization of Clostridium difficile isolates using capillary gel electrophoresis-based PCR ribotyping , 2008, Journal of medical microbiology.

[40]  C. Woods,et al.  Comparison of Seven Techniques for Typing International Epidemic Strains of Clostridium difficile: Restriction Endonuclease Analysis, Pulsed-Field Gel Electrophoresis, PCR-Ribotyping, Multilocus Sequence Typing, Multilocus Variable-Number Tandem-Repeat Analysis, Amplified Fragment Length Polymorphis , 2007, Journal of Clinical Microbiology.

[41]  T. Åkerlund,et al.  Antimicrobial Susceptibility Pattern of Clostridium difficile and Its Relation to PCR Ribotypes in a Swedish University Hospital , 2006, Antimicrobial Agents and Chemotherapy.

[42]  A. Mellmann,et al.  High Interlaboratory Reproducibility of DNA Sequence-Based Typing of Bacteria in a Multicenter Study , 2006, Journal of Clinical Microbiology.

[43]  Ken Dewar,et al.  A predominantly clonal multi-institutional outbreak of Clostridium difficile-associated diarrhea with high morbidity and mortality. , 2005, The New England journal of medicine.

[44]  Y. Arakawa,et al.  Typing by sequencing the slpA gene of Clostridium difficile strains causing multiple outbreaks in Japan. , 2005, Journal of medical microbiology.

[45]  F. Barbut,et al.  Epidemiology of Clostridium difficile-associated infections. , 2001, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[46]  I. Poilane,et al.  Comparison of the E test to the reference agar dilution method for antibiotic susceptibility testing of Clostridium difficile. , 2000, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[47]  J. Brazier,et al.  The distribution of Clostridium difficile in the environment of South Wales. , 1996, Journal of medical microbiology.